Nivedita Dharwar
Honorary Research Scientist
Nivedita Dharwar obtained her BE- Biotech from JSS Mysore followed by an MTech-Biotech from VIT University. She comes with 12+ years of experience across academia, Biotech CROs and start-ups. In and earlier startup environment, she was actively involved in the productization of CANscript ™, an ex vitro phenotypic assay platform investigating patient-specific anti-cancer drug efficacy towards offering a personalized treatment regimen.
With another start-up company, she played a key role in developing HepTox™, a liver toxicity prediction platform that integrated a Systems Model of the human liver with a series of in vitro assays to assess the cause & MOA to predict in silico, a small molecule induced DILI in humans. She possess expertise in context-specific interpretation of information from databases relevant to RNA/protein expression analysis, pathway enrichment and network building to provide in silico solutions by virtue of translational research
She has been associated with the Data Science team as a Senior research scientist at TCG Lifesciences since December 2021.